Shobha Dhadda
Eisai (United States)(US)
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research, Cholinesterase and Neurodegenerative Diseases, Health Systems, Economic Evaluations, Quality of Life, Computational Drug Discovery Methods
Most-Cited Works
- → Lecanemab in Early Alzheimer’s Disease(2022)4,787 cited
- → A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody(2021)772 cited
- → Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder(2019)388 cited
- → Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study(2017)320 cited
- → Lecanemab in patients with early Alzheimer’s disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study(2022)264 cited
- → Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients(2018)261 cited
- → The AHEAD 3‐45 Study: Design of a prevention trial for Alzheimer's disease(2022)236 cited
- → One-Year Results with Extended-Release Tacrolimus/MMF, Tacrolimus/MMF and Cyclosporine/MMF in De Novo Kidney Transplant Recipients(2007)177 cited
- → ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials(2016)156 cited
- → Efficacy and Safety of Intravenous Parecoxib Sodium in Relieving Acute Postoperative Pain following Gynecologic Laparotomy Surgery(2002)147 cited